{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:11:38Z","timestamp":1781835098941,"version":"3.54.5"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009529","name":"COMSATS Institute of Information Technology","doi-asserted-by":"crossref","award":["#16-20\/CRGP\/CIIT\/IBD\/16"],"award-info":[{"award-number":["#16-20\/CRGP\/CIIT\/IBD\/16"]}],"id":[{"id":"10.13039\/100009529","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s12031-018-1251-7","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T09:03:16Z","timestamp":1549011796000},"page":"445-455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Biochemical Analysis and Association of Butyrylcholinesterase SNPs rs3495 and rs1803274 with Substance Abuse Disorder"],"prefix":"10.1007","volume":"67","author":[{"given":"Sadaf","family":"Munir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sliha","family":"Awan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazia","family":"Bibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arooj","family":"Tanveer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajida","family":"Batool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6146-1511","authenticated-orcid":false,"given":"Syed M.","family":"Nurulain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,1]]},"reference":[{"key":"1251_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122048","volume":"10","author":"S Aeinehband","year":"2015","unstructured":"Aeinehband S, Lindblom RPF, Al Nimer F, Vijayaraghavan S, Sandholm K, Khademi M, Olsson T, Nilsson B, Ekdahl KN, Darreh-Shori T, Piehl F (2015) Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis. PLoS One 10:e0122048","journal-title":"PLoS One"},{"key":"1251_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/1098-2299(200007\/08)50:3\/4<298::AID-DDR13>3.0.CO;2-X","volume":"50","author":"Y Ashani","year":"2000","unstructured":"Ashani Y (2000) Prospective of human butyrylcholinesterase as a detoxifying antidote and potential regulator of controlled-release drugs. Drug Dev Res 50:298\u2013308","journal-title":"Drug Dev Res"},{"key":"1251_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/00952990.2014.966197","volume":"41","author":"P Askalsky","year":"2015","unstructured":"Askalsky P, Kalapatapu RK, Foltin RW, Comer SD (2015) Butyrylcholinesterase levels and subjective effects of smoked cocaine in healthy cocaine users. Am J Drug Alcohol Abuse 41:161\u2013165","journal-title":"Am J Drug Alcohol Abuse"},{"key":"1251_CR4","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00228-003-0716-x","volume":"59","author":"MO Babaoglu","year":"2004","unstructured":"Babaoglu MO, Ocal T, Bayar B, Kayaalp SO, Bozkurt A (2004) Frequency and enzyme activity of the butyrylcholinesterase K-variant in a Turkish population. Eur J Clin Pharmacol 59:875\u2013877","journal-title":"Eur J Clin Pharmacol"},{"key":"1251_CR5","doi-asserted-by":"publisher","first-page":"6171","DOI":"10.1093\/nar\/18.20.6171-a","volume":"18","author":"CF Bartels","year":"1990","unstructured":"Bartels CF, Van Der Spek AFL, La Du BN (1990) Two polymorphisms in the non-coding regions of the BCHE gene. Nucleic Acids Res 18:6171","journal-title":"Nucleic Acids Res"},{"key":"1251_CR6","first-page":"1086","volume":"50","author":"CF Bartels","year":"1992","unstructured":"Bartels CF, Jensen FS, Lockridge O, van der Spek AF, Rubinstein HM, Lubrano T, La Du BN (1992) DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am J Hum Genet 50:1086\u20131103","journal-title":"Am J Hum Genet"},{"key":"1251_CR7","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1093\/hmg\/ddr375","volume":"20","author":"B Benyamin","year":"2011","unstructured":"Benyamin B, Middelberg RP, Lind PA, Valle AM, Gordon S, Nyholt DR, Medland SE, Henders AK, Heath AC, Madden PAF, Visscher PM, O\u2019Connor DT, Montgomery GW, Martin NG, Whitfield JB (2011) GWAS of butyrylcholinesterase activity identifies four novel loci, independent effects within BCHE and secondary associations with metabolic risk factors. Hum Mol Genet 20:4504\u20134514","journal-title":"Hum Mol Genet"},{"key":"1251_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuint.2014.12.009","volume":"81","author":"GF Bono","year":"2015","unstructured":"Bono GF, Sim\u00e3o-Silva DP, Batistela MS, Josviak ND, Dias PFR, Nascimento GA, Souza RLR, Piovezan MR, Souza RKM, Furtado-Alle L (2015) Butyrylcholinesterase: K variant, plasma activity, molecular forms and rivastigmine treatment in Alzheimer\u2019s disease in a southern Brazilian population. Neurochem Int 81:57\u201362","journal-title":"Neurochem Int"},{"key":"1251_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/00221325.1995.9914832","volume":"156","author":"JS Brook","year":"1995","unstructured":"Brook JS, Newcomb MD (1995) Childhood aggression and unconventionality: impact on later academic achievement, drug use, and workforce involvement. J Genet Psychol 156:393\u2013410","journal-title":"J Genet Psychol"},{"key":"1251_CR10","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/0024-3205(96)00392-X","volume":"59","author":"GN Carmona","year":"1996","unstructured":"Carmona GN, Baum I, Schindler CW, Goldberg SR, Jufer R, Cone E, Slaughter E, Belendiuk GW, Gorelick DA (1996) Plasma butyrylcholinesterase activity and cocaine half-life differ significantly in rhesus and squirrel monkeys. Life Sci 59:939\u2013943","journal-title":"Life Sci"},{"key":"1251_CR11","first-page":"367","volume":"28","author":"GN Carmona","year":"2000","unstructured":"Carmona GN, Jufer RA, Goldberg SR, Gorelick DA, Greig NH, Yu QS, Cone EJ, Schindler CW (2000) Butyrylcholinesterase accelerates cocaine metabolism: in vitro and in vivo effects in nonhuman primates and humans. Drug Metab Dispos 28:367\u2013371","journal-title":"Drug Metab Dispos"},{"key":"1251_CR12","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1073\/pnas.1421536112","volume":"112","author":"VP Chen","year":"2015","unstructured":"Chen VP, Gao Y, Geng L, Parks RJ, Pang YP, Brimijoin S (2015) Plasma butyrylcholinesterase regulates ghrelin to control aggression. Proc Natl Acad Sci USA 112:2251\u20132256","journal-title":"Proc Natl Acad Sci USA"},{"key":"1251_CR13","first-page":"54","volume":"28","author":"AN Cokugras","year":"2003","unstructured":"Cokugras AN (2003) Butyrylcholinesterase: structure and physiological importance. Turk J Biochem 28:54\u201361","journal-title":"Turk J Biochem"},{"key":"1251_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1017\/S1041610201007876","volume":"13","author":"S Darvesh","year":"2001","unstructured":"Darvesh S, MacKnight C, Rockwood K (2001) Butyrylcholinesterase and cognitive function. Int Psychogeriatr 13:461\u2013464","journal-title":"Int Psychogeriatr"},{"key":"1251_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrn1035","volume":"4","author":"S Darvesh","year":"2003","unstructured":"Darvesh S, Hopkins DA, Geula C (2003) Neurobiology of butyrylcholinesterase. Nat Rev Neurosci 4:131\u2013138","journal-title":"Nat Rev Neurosci"},{"key":"1251_CR16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.cbi.2010.01.037","volume":"187","author":"S Darvesh","year":"2010","unstructured":"Darvesh S, Leblanc AM, Macdonald IR, Reid GA, Bhan V, Macaulay RJ, Fisk JD (2010) Butyrylcholinesterase activity in multiple sclerosis neuropathology. Chem Biol Interact 187:425\u2013431","journal-title":"Chem Biol Interact"},{"key":"1251_CR17","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1590\/1678-4685-gmb-2016-0123","volume":"40","author":"J Oliveira de","year":"2017","unstructured":"de Oliveira J, Tureck LV, Santos WD, Saliba LF, Schenknecht CS, Scaraboto D, Souza RLR, Furtado-Alle L (2017) Effect of BCHE single nucleotide polymorphisms on lipid metabolism markers in women. Genet Mol Biol 40:408\u2013414","journal-title":"Genet Mol Biol"},{"key":"1251_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101552","volume":"9","author":"H Delacour","year":"2014","unstructured":"Delacour H, Lushchekina S, Mabboux I, Bousquet A, Ceppa F, Schopfer LM, Lockridge O, Masson P (2014) Characterization of a novel BCHE \u201csilent\u201d allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium. PLoS One 9:e101552","journal-title":"PLoS One"},{"key":"1251_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88\u201395","journal-title":"Biochem Pharmacol"},{"key":"1251_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0165-1781(95)02721-8","volume":"58","author":"S Erzegovesi","year":"1995","unstructured":"Erzegovesi S, Bellodi L, Smeraldi E (1995) Serum cholinesterase in obsessive-compulsive disorder. Psychiatry Res 58:265\u2013268","journal-title":"Psychiatry Res"},{"key":"1251_CR21","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.neurobiolaging.2007.09.008","volume":"30","author":"AJ Fiocco","year":"2009","unstructured":"Fiocco AJ, Nair NPV, Schwartz G, Kin FNY, Joober R, Poirier J, Lupien SJ (2009) Influence of genetic polymorphisms in the apolipoprotein (APOE) and the butyrylcholinesterase (BCHE) gene on stress markers in older adults: a 3-year study. Neurobiol Aging 30:1001\u20131005","journal-title":"Neurobiol Aging"},{"key":"1251_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1590\/S1415-47572011000100008","volume":"34","author":"DF Garcia","year":"2011","unstructured":"Garcia DF, Oliveira TG, Molfetta GA, Garcia LV, Ferreira CA, Marques AA, Silva WA (2011) Biochemical and genetic analysis of butyrylcholinesterase (BChE) in a family, due to prolonged neuromuscular blockade after the use of succinylcholine. Genet Mol Biol 34:40\u201344","journal-title":"Genet Mol Biol"},{"key":"1251_CR23","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/0006-2952(91)90665-R","volume":"41","author":"SJ Gatley","year":"1991","unstructured":"Gatley SJ (1991) Activities of the enantiomers of cocaine and some related compounds as substrates and inhibitors of plasma butyrylcholinesterase. Biochem Pharmacol 41:1249\u20131254","journal-title":"Biochem Pharmacol"},{"key":"1251_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1749-6632.2000.tb06942.x","volume":"920","author":"E Giacobini","year":"2000","unstructured":"Giacobini E (2000) Cholinesterase inhibitors stabilize Alzheimer\u2019s disease. Ann N Y Acad Sci 920:321\u2013327","journal-title":"Ann N Y Acad Sci"},{"key":"1251_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1586\/17512433.1.2.277","volume":"1","author":"DA Gorelick","year":"2008","unstructured":"Gorelick DA (2008) Pharmacokinetic approaches to treatment of drug addiction. Expert Rev Clin Pharmacol 1:277\u2013290","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1251_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/S1415-47572014000100003","volume":"37","author":"LO Guimar\u00e3es","year":"2014","unstructured":"Guimar\u00e3es LO, de Andrade FA, Bono GF, Setoguchi TE, Brand\u00e3o MB, Chautard-Freire-Maia EA, dos Santos ICR, Picheth G, Faria AC, R\u00e9a RR, Souza RLR, Furtado-Alle L (2014) Gestational diabetes mellitus (GDM) decreases butyrylcholinesterase (BChE) activity and changes its relationship with lipids. Genet Mol Biol 37:1\u20136","journal-title":"Genet Mol Biol"},{"key":"1251_CR27","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1159\/000381532","volume":"15","author":"M Hosoi","year":"2015","unstructured":"Hosoi M, Hori K, Konishi K, Tani M, Tomioka H, Kitajima Y, Akashi N, Inamoto A, Minami S, Izuno T, Umezawa K, Horiuchi K, Hachisu M (2015) Plasma cholinesterase activity in Alzheimer\u2019s disease. Neurodegener Dis 15:188\u2013190","journal-title":"Neurodegener Dis"},{"key":"1251_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0376-8716(80)90003-4","volume":"5","author":"SG Kellam","year":"1980","unstructured":"Kellam SG, Ensminger ME, Simon MB (1980) Mental health in first grade and teenage drug, alcohol, and cigarette use. Drug Alcohol Depend 5:273\u2013304","journal-title":"Drug Alcohol Depend"},{"key":"1251_CR29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0896-6273(00)80557-7","volume":"21","author":"GF Koob","year":"1998","unstructured":"Koob GF, Sanna PP, Bloom FE (1998) Neuroscience of addiction. Neuron 21:467\u2013476","journal-title":"Neuron"},{"key":"1251_CR30","doi-asserted-by":"publisher","first-page":"5444","DOI":"10.1093\/nar\/19.19.5444","volume":"19","author":"DK Lahiri","year":"1991","unstructured":"Lahiri DK, Nurnberger JI (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444","journal-title":"Nucleic Acids Res"},{"key":"1251_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.gene.2013.08.068","volume":"532","author":"JK Lima","year":"2013","unstructured":"Lima JK, Leite N, Turek LV, Souza RLR, da Silva Timossi L, Osiecki ACV, Osiecki R, Furtado-Alle L (2013) 1914G variant of BCHE gene associated with enzyme activity, obesity and triglyceride levels. Gene 532:24\u201326","journal-title":"Gene"},{"key":"1251_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pharmthera.2014.11.011","volume":"148","author":"O Lockridge","year":"2015","unstructured":"Lockridge O (2015) Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses. Pharmacol Ther 148:34\u201346","journal-title":"Pharmacol Ther"},{"issue":"9","key":"1251_CR33","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1021\/acs.chemrestox.6b00228","volume":"29","author":"O Lockridge","year":"2016","unstructured":"Lockridge O, Norgren RB Jr, Johnson RC, Blake TA (2016) Naturally occurring genetic variants of human acetylcholinesterase and butyrylcholinesterase and their potential impact on the risk of toxicity from cholinesterase inhibitors. Chem Res Toxicol 29(9):1381\u20131392","journal-title":"Chem Res Toxicol"},{"key":"1251_CR34","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/nm1095-1082","volume":"1","author":"Y Loewenstein-Lichtenstein","year":"1995","unstructured":"Loewenstein-Lichtenstein Y, Schwarz M, Glick D, N\u00f8rgaard-Pedersen B, Zakut H, Soreq H (1995) Genetic predisposition to adverse consequences of anti-cholinesterases in \u201catypical\u201d BCHE carriers. Nat Med 1:1082\u20131085","journal-title":"Nat Med"},{"key":"1251_CR35","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1176\/ajp.137.9.1118","volume":"137","author":"RJ Mathew","year":"1980","unstructured":"Mathew RJ, Hsu LL, Semchuk KM, Claghorn JL (1980) Acetylcholinesterase and pseudocholinesterase activities in anxiety. Am J Psychiatry 137:1118\u20131120","journal-title":"Am J Psychiatry"},{"key":"1251_CR36","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1176\/ajp.139.1.125","volume":"139","author":"RJ Mathew","year":"1982","unstructured":"Mathew RJ, Ho BT, Khan MM, Perales C, Weinman ML, Claghorn JL (1982) True and pseudo cholinesterases in depression. Am J Psychiatry 139:125\u2013127","journal-title":"Am J Psychiatry"},{"key":"1251_CR37","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/B978-0-12-398335-0.00052-2","volume-title":"Biological research on addiction","author":"MR Meyer","year":"2013","unstructured":"Meyer MR (2013) The genetics of drugs of abuse metabolism. In: Miller PM (ed) Biological research on addiction. Academic Press, San Diego, pp 533\u2013540"},{"key":"1251_CR38","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/0006-3223(87)90031-X","volume":"22","author":"I Modai","year":"1987","unstructured":"Modai I, Schwartz B, Aizenberg D (1987) Serum pseudocholinesterase in psychiatric patients. Biol Psychiatry 22:1238\u20131242","journal-title":"Biol Psychiatry"},{"key":"1251_CR39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.sjbs.2014.05.003","volume":"22","author":"G Mushtaq","year":"2015","unstructured":"Mushtaq G, Khan JA, Kumosani TA, Kamal MA (2015) Alzheimer\u2019s disease and type 2 diabetes via chronic inflammatory mechanisms. Saudi J Biol Sci 22:4\u201313","journal-title":"Saudi J Biol Sci"},{"key":"1251_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080505","volume":"8","author":"AB Negr\u00e3o","year":"2013","unstructured":"Negr\u00e3o AB, Pereira AC, Guindalini C, Santos HC, Messas GP, Laranjeira R, Vallada H (2013) Butyrylcholinesterase genetic variants: association with cocaine dependence and related phenotypes. PLoS One 8:e80505","journal-title":"PLoS One"},{"key":"1251_CR41","doi-asserted-by":"crossref","first-page":"431","DOI":"10.31887\/DCNS.2013.15.4\/enestler","volume":"15","author":"EJ Nestler","year":"2013","unstructured":"Nestler EJ (2013) Cellular basis of memory for addiction. Dialogues Clin Neurosci 15:431\u2013443","journal-title":"Dialogues Clin Neurosci"},{"key":"1251_CR42","doi-asserted-by":"publisher","unstructured":"Nordberg A, Ballard C, Bullock R, Darreh-Shori T, Somogyi M (2013) A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer\u2019s disease. Prim Care Companion CNS Disord 15(2). https:\/\/doi.org\/10.4088\/PCC.12r01412","DOI":"10.4088\/PCC.12r01412"},{"key":"1251_CR43","first-page":"779","volume":"2","author":"M Oguri","year":"2009","unstructured":"Oguri M, Kato K, Yokoi K, Yoshida T, Watanabe S, Metoki N, Yoshida H, Satoh K, Aoyagi Y, Tanaka M, Nozawa Y, Yamada Y (2009) Association of a polymorphism of BCHE with ischemic stroke in Japanese individuals with chronic kidney disease. Mol Med Rep 2:779\u2013785","journal-title":"Mol Med Rep"},{"key":"1251_CR44","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1139\/y83-132","volume":"61","author":"JA Owen","year":"1983","unstructured":"Owen JA, Nakatsu K (1983) Diacetylmorphine (heroin) hydrolases in human blood. Can J Physiol Pharmacol 61:870\u2013875","journal-title":"Can J Physiol Pharmacol"},{"key":"1251_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12872-015-0128-8","volume":"15","author":"L Pleva","year":"2015","unstructured":"Pleva L, Kovarova P, Faldynova L, Plevova P, Hilscherova S, Zapletalova J, Kusnierova P, Kukla P (2015) The rs1803274 polymorphism of the BCHE gene is associated with an increased risk of coronary in-stent restenosis. BMC Cardiovasc Disord 15:135","journal-title":"BMC Cardiovasc Disord"},{"key":"1251_CR46","first-page":"52","volume":"58","author":"SL Primo-Parmo","year":"1996","unstructured":"Primo-Parmo SL, Bartels CF, Wiersema B, van der Spek AF, Innis JW, La Du BN (1996) Characterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene. Am J Hum Genet 58:52\u201364","journal-title":"Am J Hum Genet"},{"key":"1251_CR47","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.neuroscience.2015.04.039","volume":"298","author":"GA Reid","year":"2015","unstructured":"Reid GA, Darvesh S (2015) Butyrylcholinesterase-knockout reduces brain deposition of fibrillar \u03b2-amyloid in an Alzheimer mouse model. Neuroscience 298:424\u2013435","journal-title":"Neuroscience"},{"key":"1251_CR48","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1046\/j.1440-1681.1999.03090.x","volume":"26","author":"AY Salmon","year":"1999","unstructured":"Salmon AY, Goren Z, Avissar Y, Soreq H (1999) Human erythrocyte but not brain acetylcholinesterase hydrolyses heroin to morphine. Clin Exp Pharmacol Physiol 26:596\u2013600","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1251_CR49","unstructured":"Shields KA, Lewis J (2018) The identification of butyrycholinesterase (BCHE) polymorphisms in a small Australian Defence force cohort. http:\/\/www.dsto.defence.gov.au\/corporate\/reports\/DSTO-TR-2503.pdf . Accessed 28 July 2018"},{"issue":"Suppl 2","key":"1251_CR50","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/jnc.13928","volume":"142","author":"A Simchovitz","year":"2017","unstructured":"Simchovitz A, Heneka MT, Soreq H (2017) Personalized genetics of the cholinergic blockade of neuroinflammation. J Neurochem 142[Suppl 2]:178\u2013171","journal-title":"J Neurochem"},{"key":"1251_CR51","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12291-014-0443-3","volume":"30","author":"S Tangvarasittichai","year":"2015","unstructured":"Tangvarasittichai S, Pongthaisong S, Meemark S, Tangvarasittichai O (2015) Abdominal obesity associated with elevated serum Butyrylcholinesterase activity, insulin resistance and reduced high density lipoprotein-cholesterol levels. Indian J Clin Biochem 30:275\u2013280","journal-title":"Indian J Clin Biochem"},{"key":"1251_CR52","unstructured":"UNODC (United Nations Office on Drugs and Crime) (2013) Drugs use in Pakistan. https:\/\/www.unodc.org\/documents\/pakistan\/Survey_Report_Final_2013.pdf . Accessed 28 July 2018"},{"key":"1251_CR53","unstructured":"UNODC (United Nations Office on Drugs and Crime) (2016) World drug report 2016\u2014world. https:\/\/reliefweb.int\/report\/world\/unodc-world-drug-report-2016 . Accessed 28 July 2018"},{"key":"1251_CR54","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1373\/clinchem.2005.065052","volume":"52","author":"A Valle","year":"2006","unstructured":"Valle A, O\u2019Connor DT, Taylor P, Zhu G, Montgomery GW, Slagboom PE, Martin NG, Whitfield JB (2006) Butyrylcholinesterase: association with the metabolic syndrome and identification of 2 gene loci affecting activity. Clin Chem 52:1014\u20131020","journal-title":"Clin Chem"},{"key":"1251_CR55","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1146\/annurev-genom-090711-163844","volume":"13","author":"J-C Wang","year":"2012","unstructured":"Wang J-C, Kapoor M, Goate AM (2012) The genetics of substance dependence. Annu Rev Genomics Hum Genet 13:241\u2013261. https:\/\/doi.org\/10.1146\/annurev-genom-090711-163844","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"1251_CR56","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0009-8981(99)00144-8","volume":"288","author":"F Worek","year":"1999","unstructured":"Worek F, Mast U, Kiderlen D, Diepold C, Eyer P (1999) Improved determination of acetylcholinesterase activity in human whole blood. Clin Chim Acta 288:73\u201390","journal-title":"Clin Chim Acta"},{"key":"1251_CR57","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1093\/nar\/20.5.1152","volume":"20","author":"S Ye","year":"1992","unstructured":"Ye S, Humphries S, Green F (1992) Allele specific amplification by tetra-primer PCR. Nucleic Acids Res 20:1152","journal-title":"Nucleic Acids Res"},{"key":"1251_CR58","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1373\/49.8.1297","volume":"49","author":"T Ye","year":"2003","unstructured":"Ye T, Nightingale BN, Burns JC, Sullivan DR, Stewart PM (2003) Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population. Clin Chem 49:1297\u20131308","journal-title":"Clin Chem"},{"key":"1251_CR59","doi-asserted-by":"crossref","unstructured":"Zaman M, Razzaq S, Hassan R, Qureshi J, Ijaz H, Hanif M, Rahman Chughtai F (2015) Drug abuse among the students. Pakistan J Pharmaceutical Res 1(1)41\u201347","DOI":"10.22200\/pjpr.2015141-47"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-018-1251-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-018-1251-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-018-1251-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T01:44:31Z","timestamp":1606355071000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-018-1251-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1251"],"URL":"https:\/\/doi.org\/10.1007\/s12031-018-1251-7","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,1]]},"assertion":[{"value":"31 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflicts of interest and no financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}